Patent Assignment
Reel/Frame 016674/0980
Release of Security Interest
Recorded: 2005-10-26
Received: 2005-10-26
Pages: 12
Assignor
BANK OF AMERICA, N.A., AS AGENT
Executed: 2005-10-19
Assignees
ANDA, INC.
8151 PETERS ROAD, 4TH FLOOR, PLANTATION, FL, 33324, UNITED STATES
ANDRX CORPORATION
8151 PETERS ROAD, 4TH FLOOR, PLANTATION, FL, 33324, UNITED STATES
ANDRX LABS, LLC
8151 PETERS ROAD, 4TH FLOOR, PLANTATION, FL, 33324, UNITED STATES
ANDRX LABORATORIES, INC.
8151 PETERS ROAD, 4TH FLOOR, PLANTATION, FL, 33324, UNITED STATES
ANDRX LABS, INC.
8151 PETERS ROAD, 4TH FLOOR, PLANTATION, FL, 33324, UNITED STATES
ANDRX PHARMACEUTICALS, LLC
8151 PETERS ROAD, 4TH FLOOR, PLANTATION, FL, 33324, UNITED STATES
CYBEAR, LLC
8151 PETERS ROAD, 4TH FLOOR, PLANTATION, FL, 33324, UNITED STATES
MEDICONSULT.COM, INC.
8151 PETERS ROAD, 4TH FLOOR, PLANTATION, FL, 33324, UNITED STATES
Covered Properties
(45)
Controlled release metformin compositions
Application:
10/796,411 →
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Application:
10/777,542 →
Dosage Form Holder Device and Methods for Immersion Testing
Application:
10/768,277 →
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
Application:
60/537,862 →
Extended Release Venlafaxine Formulation
Application:
10/715,219 →
Omeprazole Formulation
Application:
10/712,505 →
Decongestant and expectorant system
Application:
60/516,983 →
Itraconazole immediate release formulation
Application:
10/679,760 →
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Application:
10/664,803 →
System and method for pharmacy restocking applications
Application:
10/637,816 →
Pharmaceutical formulation
Application:
10/634,321 →
Formulation and Process for Drug Loaded Cores
Application:
10/617,456 →
Divalproex sodium tablets
Application:
10/465,702 →
Biguanide formulations
Application:
10/442,692 →
Apparatus and techniques for pharmacy restocking applications
Application:
60/457,475 →
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
Application:
60/442,337 →
Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
Application:
10/337,444 →
Granule modulating hydrogel system
Application:
10/335,767 →
Stable Pharmaceutical Compositions Without a Stabilizer
Application:
10/301,474 →
Antihistamine and Decongestant System
Application:
10/291,103 →
Omeprazole Formulation
Application:
10/279,622 →
Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Application:
60/412,180 →
Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Application:
60/412,181 →
Once a Day Antihistamine and Decongestant Formulation
Application:
10/244,452 →
Apparatus and techniques for pharmacy restocking applications
Application:
60/402,069 →
Rapidly disintegrating antihistamine formulation
Application:
10/183,771 →
Controlled release oral dosage form
Application:
10/183,776 →
Controlled release compositions for drugs having pH dependent solubility
Application:
60/388,704 →
Biguanide formulations
Application:
60/382,652 →
Controlled Release Oral Dosage Form of Beta-Adrenergic Blocking Agents
Application:
10/109,408 →
Controlled release sulfonylurea formulation
Application:
10/101,438 →
Controlled release oral dosage form
Application:
10/071,257 →
Method of treating amyloid beta precursor disorders
Application:
10/067,593 →
Apparatus and method for removing particulate created from a drilled tablet
Application:
60/344,904 →
Gabapentin Prodrugs and Formulations
Application:
10/040,251 →
Packaging system
Application:
09/970,049 →
Composition for the Treatment and Prevention of Ischemic Events
Application:
09/950,536 →
Computerized Prescription System for Gathering and Presenting Information Relating to Pharmaceuticals
Application:
09/941,681 →
Computerized Prescription System for Gathering and Presenting Information Relating to Pharmaceuticals
Application:
09/941,841 →
Prescription Management System
Application:
09/941,682 →
Omeprazole Formulation
Application:
09/763,831 →
Serotonin Reuptake Inhibitor Formulations
Application:
09/785,040 →
Divalproex Sodium Tablets
Application:
09/785,069 →
Controlled release oral dosage form
Application:
09/905,690 →
Controlled Release Oral Dosage Form
Application:
09/905,712 →